United Kingdom · Question · Written question
UIN 50771
Hormone Replacement Therapy
Introduced
7 May 2025
Last action
12 May 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
12 May 2025
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2025 to Question 35541 on Hormone Replacement Therapy, what discussions he has had with the Medicines and Healthcare products Regulatory Agency on the adequacy of
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 May 2025
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2025 to Question 35541 on Hormone Replacement Therapy, what discussions he has had with the Medicines and Healthcare products Regulatory Agency on the adequacy of
Source: Commons
12 May 2025
Answer
The processes of the Medicines and Healthcare products Regulatory Agency (MHRA) are now performing within the expected timelines, and are meeting company commitments. Guidance has been updated on 3 April 2024 to aid the rapid approval of medicines, ensuri...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-05-07/50771
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1800700
- uk · wq-1800700 · source updated 12 May 2025